← Eichor
Condition: Gout And Hyperuricemia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gout And Hyperuricemia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
Phase 4 · 1 location(s) · Huashan Hospital · NCT06966635SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial
Phase 4 · 1 location(s) · Massachusetts General Hospital · NCT06674109Effect of Dotinurad in Hyperuricemia With Hypertension
Phase 4 · 1 location(s) · Saga University · NCT06834230A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens,
Phase 2 · 27 location(s) · Protalix · NCT07280156A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · 86 location(s) · Crystalys Therapeutics · NCT07089888Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic Hyperuricaemia
NA · 1 location(s) · OMNIFARMA LLC · NCT07002762The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hy
Phase 2 · 1 location(s) · Jiangsu HengRui Medicine Co., Ltd. · NCT07362355Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Phase 1 · 1 location(s) · Shenyang Sunshine Pharmaceutical Co., LTD. · NCT06629376Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia
NA · 1 location(s) · Beijing Zhecheng Biotechnology Co., Ltd. · NCT07613138Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Phase N/A · 1 location(s) · Osaka Metropolitan University · NCT06694012A Study of Dotinurad Versus Allopurinol in Participants With Gout
Phase 3 · 100 location(s) · Crystalys Therapeutics · NCT07089875Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
Phase 2/Phase 3 · 40 location(s) · Olatec Therapeutics, Inc. · NCT05658575
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.